DataMeds AI (MEDS) director Peterson sold 900 shares for $4,212 at $4.68 under a 10b5-1 plan
Insider transactions reported
Michael L Peterson (director at DataMeds AI Inc., MEDS) reported that they sold 900 shares for $4,212 at $4.68, and received 10,721 shares on Apr 19, 2021. After these transactions the filing shows 17,008 shares held directly.
- Reporting person
- Peterson Michael L
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Apr 19, 2021 | Open-market sale (S) | Common stock1, 2 | -900 | $4.68 | $4,212 | 6,287 direct |
| Apr 19, 2021 | Grant or award (A) | Common stock3, 4 | +10,721 | $5.13 | $55K | 17,008 direct |
Holdings before and after
- Common stock: 7,187 to 17,008 direct
Footnotes from the filing
- 1. The shares were sold pursuant to a 10b5-1 trading plan previously adopted by the Reporting Person, to satisfy the Reporting Person's tax liability in connection with the April 2021 vesting of certain restricted stock shares which were granted under the Company's 2019 Equity Incentive Plan, which award was exempt from Section 16(b) pursuant to Rule 16b-3.
- 2. This transaction was executed in multiple trades at prices ranging from $4.63 to $4.77, with the price reported above reflecting the weighted average sales price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was affected.
- 3. Shares of Restricted Common Stock were issued to the Reporting Person pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan and are subject to forfeiture. The shares vest at the rate of 1/4 of the shares on July 1 and October 1, 2021 and January 1 and April 1, 2022, subject to the Reporting Person's continued service to the Company on such vesting dates, and subject to the terms and conditions of a Restricted Shares Grant Agreement entered into by and between the Issuer and the Reporting Person. Exempt under Rule 16b-3(d).
- 4. Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a member of the Board of Directors.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Grant or award:
- Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.
FAQ
What did Peterson report in this MEDS Form 4?
Michael L Peterson (director at DataMeds AI Inc., MEDS) reported that they sold 900 shares for $4,212 at $4.68, and received 10,721 shares on Apr 19, 2021. After these transactions the filing shows 17,008 shares held directly.
How many MEDS shares does Peterson hold after this filing?
The filing shows 17,008 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this MEDS insider sale made under a 10b5-1 plan?
The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for MEDS
Earlier insider filings at MEDS
- Apr 20, 2021SEC Form 4: Tenaerts Pamela was granted 10,721 units of Common stock, increasing direct ownership by 131% to 18,908 units
- Apr 15, 2021SEC Form 4: Fell Donald G. was granted 8,987 units of Common stock, increasing direct ownership by 916% to 9,968 units (Amendment)
- Apr 15, 2021SEC Form 4: Fell Donald G. sold $2,650 worth of Common stock (500 units at $5.30), decreasing direct ownership by 5% to 9,468 units (Amendment)
- Apr 15, 2021SEC Form 4: Fell Donald G. gifted 6,700 units of Common Stock, increasing direct ownership by 258% to 981 units
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Other Pharmaceuticals
Follow MEDS and get a push notification the moment its next story breaks.